ESC 365 - Discontinuation of diuretic therapy is safe in accurately selected patients with chronic heart failure and severely reduced ejection fraction: a prospective cohort study in the outpatients setting

HFA Premium Access

Discontinuation of diuretic therapy is safe in accurately selected patients with chronic heart failure and severely reduced ejection fraction: a prospective cohort study in the outpatients setting

Session: Poster Session 3 - Diuretics and fluid status management

Topic: Diuretics

Speaker: Doctor C. Mina (Palermo, IT)

Event: HEART FAILURE 2016

Congress Presentation

Add to my library

About the speaker

Doctor Chiara Mina

Mediterranean Institute for Transplantation and High Specialization Therapies (IsMeTT), Palermo (Italy)

0 follower

9 more presentations in this session

Heart failure with preserved ejection fraction: does the intra-venous diuretic treatment duration matter?

Speaker: Doctor J. Ribeiro (Porto, PT)

Blood purification in end-stage heart failure: a study in 16 patients

What are predictive factors for body weight loss in patients with acute decompensated heart failure added an oral aquaretic, tolvaptan ?

Speaker: Doctor T. Ando (Nishinomiya, JP)

Influence of clinical severity on the association of loop diuretic dose with mortality in patients with heart failure: insights from the unite-hf registry

Speaker: Doctor K. Adams Jr (Chapel Hill, US)

Diuretic resistance and chronic renal disease, how to face it?

Speaker: Miss R. Eiros (Salamanca, ES)

Access the full session

Poster Session 3 - Diuretics and fluid status management

Speakers: Doctor C. Mina, Doctor J. Ribeiro, Doctor T. Ando, Doctor K. Adams Jr, Miss R. Eiros

About the event

HEART FAILURE 2016

21 May - 24 May 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources